Human PON3, effects beyond the HDL: Clues from human PON3 transgenic mice

Circulation Research

Volumn 100, Issue 8, 2007, Pages 1104-1105

  Draganov, Dragomir I ^a  

^a WIL RESEARCH LABORATORIES   (United States)

Author keywords

Interspecies differences; Lactonase; PON3

Indexed keywords

AMINO ACID; ANTIOXIDANT; APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN; PARAOXONASE 3; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; AMINO TERMINAL SEQUENCE; ATHEROGENIC DIET; ATHEROSCLEROSIS; BRAIN TISSUE; CELL ISOLATION; CELL MEMBRANE; CELLULAR DISTRIBUTION; CHEMICAL ANALYSIS; EDITORIAL; ENZYME ACTIVITY; ENZYME SPECIFICITY; GASTROINTESTINAL TRACT; GENETIC TRANSFECTION; HUMAN; KIDNEY; LIVER; LUNG; MULTIGENE FAMILY; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT; SEX DIFFERENCE; TISSUE DISTRIBUTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; ESTERASES; FEMALE; HUMANS; LIPOPROTEINS, HDL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; SPECIES SPECIFICITY;

EID: 34247556498     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000266976.89667.31     Document Type: Editorial

References (22)

1. Shih DM, Xia YR, Wang XP, Wang SS, Bourquard N, Fogelman AM, Lusis AJ, Reddy ST. Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice. Circ Res. 2007;100:1200-1207.
2. Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics. 1996;33:498-507.
3. Draganov DI, La Du BN. Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol. 2004;369:78-88.
4. Khersonsky O, Tawfik DS. Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase. Biochemistry. 2005;44:6371-6382.
5. Draganov DI, Teiber JF, Speelman A, Osawa Y, Sunahara R, La Du BN. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J Lipid Res. 2005;46:1239-1247.
6. Aviram M, Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med. 2004;37:1304-1316.
7. Ng CJ, Shih DM, Hama SY, Villa N, Navab M, Reddy ST. The paraoxonase gene family and atherosclerosis. Free Radic Biol Med. 2005;38:153-163.
8. Draganov DI, Stetson PL, Watson CE, Billecke SS, La Du BN. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J Biol Chem. 2000;275:33435-33442.
9. Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Gangopadhyay A, Shih DM, Lusis AJ, Navab M, Fogelman AM. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol. 2001;21:542-547.
10. La Du BN. Is paraoxonase-3 another HDL-associated protein protective against atherosclerosis? Arterioscler Thromb Vasc Biol. 2001;21:467-468.
11. Ozols J. Isolation and complete covalent structure of liver microsomal paraoxonase. Biochem J. 1999;338(Pt 2):265-272.
12. Rodrigo L, Gil F, Hernandez AF, Lopez O, Pla A. Identification of paraoxonase 3 in rat liver microsomes: purification and biochemical properties. Biochem J. 2003;376(Pt 1):261-268.
13. Shamir R, Hartman C, Karry R, Pavlotzky E, Eliakim R, Lachter J, Suissa A, Aviram M. Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2. Free Radic Biol Med. 2005;39:336-344.
14. Ozer EA, Pezzulo A, Shih DM, Chun C, Furlong C, Lusis AJ, Greenberg EP, Zabner J. Human and murine paraoxonase 1 are host modulators of Pseudomonas aeruginosa quorum-sensing. FEMS Microbiol Lett. 2005;253:29-37.
15. Rosenblat M, Draganov D, Watson CE, Bisgaier CL, La Du BN, Aviram M. Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress. Arterioscler Thromb Vasc Biol. 2003;23:468-474.
16. Draganov DI, Sass KM, Watson CE, Bisgaier CL, Reddy ST, Teiber JF, La Du BN. The N-terminal sequences of human paraoxonase-1 (PON1) and paraoxonase-3 (PON3) are responsible for their different translocation and secretion. Circulation. 2002;106(II):123.
17. Deakin S, Leviev I, Gomaraschi M, Calabresi L, Franceschini G, James RW. Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J Biol Chem. 2002;277:4301-4308.
18. Stoltz DA, Ozer EA, Ng CJ, Yu J, Reddy ST, Lusis AJ, Bourquard N, Parsek MR, Zabner J, Shih DM. Paraoxonase-2 Deficiency Enhances Pseudomonas aeruginosa Quorum Sensing in Murine Tracheal Epithelia. Am J Physiol Lung Cell Mol Physiol. 2006. In press.
19. Gordon DA, Jamil H. Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Biochim Biophys Acta. 2000;1486:72-83.
20. Swift LL, Kakkad B, Boone C, Jovanovska A, Jerome WG, Mohler PJ, Ong DE. Microsomal triglyceride transfer protein expression in adipocytes: a new component in fat metabolism. FEBS Lett. 2005;579:3183-3189.
21. Tangirala RK, Rubin EM, Palinski W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res. 1995;36:2320-2208.
22. Winnier DA, Rainwater DL, Cole SA, Williams JT, Dyer TD, Blangero J, MacCluer JW, Mahaney MC. Sex-specific QTL effects on variation in paraoxonase 1 (PON1) activity in Mexican Americans. Genet Epidemiol. 2007;31:66-74.